These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 22232060)

  • 1. Exact sample-size determination in testing non-inferiority under a simple crossover trial.
    Lui KJ; Chang KC
    Pharm Stat; 2012; 11(2):129-34. PubMed ID: 22232060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Test non-inferiority (and equivalence) based on the odds ratio under a simple crossover trial.
    Lui KJ; Chang KC
    Stat Med; 2011 May; 30(11):1230-42. PubMed ID: 21538451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis testing and estimation in ordinal data under a simple crossover design.
    Lui KJ; Chang KC
    J Biopharm Stat; 2012; 22(6):1137-47. PubMed ID: 23075013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo.
    Pigeot I; Schäfer J; Röhmel J; Hauschke D
    Stat Med; 2003 Mar; 22(6):883-99. PubMed ID: 12627407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size determination for testing equality in Poisson frequency data under an AB/BA crossover trial.
    Lui KJ
    Pharm Stat; 2013; 12(2):74-81. PubMed ID: 23364859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test non-inferiority and sample size determination based on the odds ratio under a cluster randomized trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2011 Jan; 21(1):94-110. PubMed ID: 21191857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blinded sample size reassessment in non-inferiority and equivalence trials.
    Friede T; Kieser M
    Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M
    Pharm Stat; 2007; 6(1):43-52. PubMed ID: 17323311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma management: the challenge of equivalence.
    Steinijans VW; Neuhäuser M; Hummel T; Leichtl S; Rathgeb F; Keller A
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):117-25. PubMed ID: 9562226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A note on sample size calculation for mean comparisons based on noncentral t-statistics.
    Chow SC; Shao J; Wang H
    J Biopharm Stat; 2002 Nov; 12(4):441-56. PubMed ID: 12477068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-parametric assessment of non-inferiority with censored data.
    Freitag G; Lange S; Munk A
    Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulae and tables for the determination of sample sizes and power in clinical trials for testing differences in proportions for the two-sample design: a review.
    Sahai H; Khurshid A
    Stat Med; 1996 Jan; 15(1):1-21. PubMed ID: 8614740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new test of non-inferiority for anti-infective trials.
    Phillips KF
    Stat Med; 2003 Jan; 22(2):201-12. PubMed ID: 12520557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
    Lai TL; Shih MC; Zhu G
    Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ; Hung HM; Tsong Y; Cui L
    Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notes on testing non-inferiority under the partial verification design with a confirmatory procedure limited to screen positives.
    Lui KJ
    Contemp Clin Trials; 2012 May; 33(3):563-71. PubMed ID: 22366778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of non-inferiority in a gold standard design with censored, exponentially distributed endpoints.
    Mielke M; Munk A; Schacht A
    Stat Med; 2008 Nov; 27(25):5093-110. PubMed ID: 18570271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.